Drug intelligence / Profile preview

Baoyuan Paidu Wan

Development stage
Unknown
Lead developer
ABM Therapeutics Corporation
Modality
Small Molecules
Administration
Oral
01

Overview

Baoyuan Paidu Wan is a Traditional Chinese Medicine (TCM) formulation primarily indicated for the treatment of chronic renal failure (CRF) and chronic kidney disease (CKD). It is designed to tonify qi and remove toxins, which clinically translates to improving renal function and reducing levels of metabolic waste products such as blood urea nitrogen (BUN) and serum creatinine (SCr). The formulation typically contains a combination of herbs including *Astragalus membranaceus* (Huangqi), *Rheum palmatum* (Dahuang), *Salvia miltiorrhiza* (Danshen), and *Ligusticum chuanxiong*. Its mechanism of action involves improving renal microcirculation, inhibiting inflammatory cytokines like TNF-alpha and IL-6, and suppressing the TGF-beta1 signaling pathway to delay renal fibrosis. It is commonly used in China as a supportive therapy to slow the progression of kidney disease and manage uremic symptoms.

Brand names
Baoyuan Paidu Wan
Other names
Baoyuan Paiduan保元排毒丸Baoyuan Paidu Pill
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))TGFB1 (Transforming growth factor Beta-1 proprotein)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on Baoyuan Paidu Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baoyuan Paidu Wan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call